- Research article
- Open Access
- Open Peer Review
A cross-sectional study of the clinical characteristics of hospitalized children with community-acquired pneumonia in eight eastern cities in China
- Xue-Feng Wang†1Email author,
- Jian-Ping Liu†2Email author,
- Kun-Ling Shen3,
- Rong Ma4,
- Zhen-Ze Cui5,
- Li Deng6,
- Yun-Xiao Shang7,
- De-Yu Zhao8,
- Li-Bo Wang9,
- Li-Ya Wan10,
- Yi-Qiu Sun11,
- Yan-Ning Li12,
- Zhi-Yan Jiang13,
- Hua Xu14,
- Xin-Min Li4,
- Zhen-Qi Wu1,
- Zhao-Lan Liu2,
- Ying-Hui Hu3,
- Yan Huang5,
- Chun-Hui He6,
- Han Zhang7,
- Yong-Hong Jiang13,
- Hua Liu14 and
- Zi Wang1
© Wang et al.; licensee BioMed Central Ltd. 2013
- Received: 28 May 2013
- Accepted: 16 December 2013
- Published: 23 December 2013
Community-acquired pneumonia in children is common in China. To understand current clinical characteristics and practice, we conducted a cross-sectional study to analyze quality of care on childhood pneumonia in eight eastern cities in China.
Consecutive hospital records between January 1, 2010 and December 31, 2010 were collected from 13 traditional Chinese medicine (TCM) and western medicine (WM) hospitals in February, May, August, and November (25 cases per season, 100 cases over the year), respectively. A predesigned case report form was used to extract data from the hospital medical records.
A total of 1298 cases were collected and analyzed. Symptoms and signs upon admission at TCM and WM hospitals were cough (99.3% vs. 98.6%), rales (84.8% vs. 75.0%), phlegm (83.3% vs. 49.1%), and fever (74.9% vs. 84.0%) in frequency. Patients admitted to WM hospitals had symptoms and signs for a longer period prior to admission than patients admitted to TCM hospitals. Testing to identify etiologic agents was performed in 1140 cases (88.4%). Intravenous antibiotics were administered in 99.3% (595/598) of cases in TCM hospitals and in 98.6% (699/700) of cases in WM hospitals. Besides, Chinese herbal extract injection was used more frequently in TCM hospitals (491 cases, 82.1%) than in WM hospitals (212 cases, 30.3%) (p < 0.01). At discharge, 818 cases (63.0%) were clinically cured, with a significant difference between the cure rates in TCM (87.6%) and WM hospitals (42.0%) (OR = 9.8, 95% confidence interval (CI): 7.3 ~ 12.9, p < 0.01). Pathogen and previous medical history were more likely associated with the disappearance of rales (OR = 7.2, 95% CI: 4.8 ~ 10.9). Adverse effects were not reported from the medical records.
Intravenous use of antibiotics is highly prevalent in children with community-acquired pneumonia regardless of aetiology. There was difference between TCM and WM hospitals with regard to symptom profile and the use of antibiotics. Intravenous use of herbal injection was higher in TCM hospitals than in WM hospitals. Most of the cases were diagnosed based on clinical signs and symptoms without sufficient confirmation of aetiology. Audit of current practice is urgently needed to improve care.
- Childhood pneumonia
- Clinical characteristics
- Cross-sectional study
- Chinese population
Pneumonia is an inflammatory condition of the lung, caused by different pathogens or other etiologic factors . Worldwide it is the leading cause of death in children under five years old [2–4], with nearly 2 million deaths, or almost 19.0% of total deaths in children . In China, it is estimated that there are an annual 21.1 million new cases of pneumonia in children younger than 5 years of age. This is a disease burden second only to India, which has 43 million annual new cases in the same age group [6, 7]. In China, pneumonia accounts for most pediatric hospitalizations .
Addressing childhood pneumonia remains a difficult public health task in China. In terms of surveillance, pneumonia is not even listed as a national notifiable infectious disease , though in 2003 after the outbreak of severe acute respiratory syndrome (SARS), “pneumonia of unknown cause” was required to be reported because airborne etiologic agents such as the SARS coronavirus and human avian influenza virus (H5N1) are extremely pathogenic and capable of quickly causing an epidemic . Moreover, China’s current health policy of “integration of TCM and Western medicine” need large-scale surveys comparing cases of childhood pneumonia at TCM and WM hospitals. Whether for guiding healthcare policy or for improving disease management and prevention, evaluating quality of care in paediatric pneumonia is of paramount importance. Through the ages, WM hospitals hold a principle status in public health. TCM hospitals are gradually into mass vision, although at most time as a complementary role. The two types of hospitals have advantages and disadvantages. Commonly, WM hospitals prefer to acute severe disease, and TCM hospitals prefer to chronic mild disease. To exploring specific difference on pneumonia therapy between two types of hospitals, this cross-sectional study was designed to investigate the distribution, diagnosis, treatment, and clinical outcome of childhood community-acquired pneumonia in China.
Data were drawn from 13 traditional Chinese medicine (TCM) and western medicine (WM) hospitals in eight eastern cities of China: Beijing, Dalian, Guangzhou, Jinan, Nanjing, Shanghai, Shenyang, and Tianjin. Hospitals selection refers to region representation as provincial capitals or coast cities, which reflects a better status of economic and health in China. The hospitals are either affiliated with universities or are provincial/municipal children’s hospitals. Our protocol of study was approved by institutional review board (IRB) of the affiliated hospital of Liaoning University of Traditional Chinese Medicine (principle investigator) which covered each hospital’s IRB.
Children between 1 and 14 years of age presenting to the pediatric ward with clinical diagnosis of community-acquired pneumonia were eligible for the study. Our previous study [11–14] found that admission rates and numbers of severe pneumonia cases, especially in children <1 year of age, between TCM and WM hospitals were highly incongruent. Therefore, to avoid bias in the current study, we excluded children younger than one year old and children with severe pneumonia. Indications for severe pneumonia in patient age 0–3 years were temperature >38.5°C, respiratory rate (RR) >70 breaths/min, chest retractions, nasal flaring, cyanosis, intermittent apnea, grunting, not feeding. Indications for severe pneumonia in patient age 4–14 years were temperature >38.5°C, RR >50 breaths/min, nasal flaring, cyanosis, grunting, and signs of dehydration.
Criteria of diagnosis were based on nationally-recognized guidelines from either the Chinese Medical Association  or Zhu Futang Textbook of Pediatrics, with symptoms of fever, cough and dyspnea, fixed fine moist rales, and patchy infiltrates on chest radiography. Criteria for clinical therapeutic effectivness were also based on national guidelines [15, 16]. Clinical cure was defined as temperature ≤37.2°C, disappearance of all symptoms except occasional cough, and disappearance of rales. Clinical improvement was defined as ≤37.2°C, all symptoms and rales reduced. Failure was defined as no improvement in presenting symptoms.
Data sampling was from January 1, 2010 to December 31, 2010. Total study sample was 1300. Consecutive hospitalised records of children with paediatric pneumonia were collected from each hospital in February, May, August, and November, respectively, that is, first consecutive 25 cases each month, or 100 cases per hospital over the 1-year study period.
A predesigned case report form was applied by trained investigators with clinical medicine backgrounds. Information extracted were demographic data including name, gender, age, hospital case number, birth history (route of delivery, birth weight), past medical history (recurrent respiratory tract diseases, eczema, asthma, allergic rhinitis, and other allergies), duration of hospital stay, symptoms and signs up to admission, diagnosis on admission and at discharge, therapy modalities, and clinical outcome at discharge. All records were input into an electronic database based on EpiData software version 3.1.
EpiData software version 3.1 and IBM SPSS software version 17.0 were used for record and data analyses. All p values were applied with two-tailed tests and were not adjusted for multiple testing. Logistic regression model was used to explore the relationship between different types of hospitals and the improvement of symptoms.
Characteristics of children hospitalised with pneumonia in the sampled hospitals
Number (n = 598)
Number (n = 700)
Previous medical history
Clinical manifestations on admission
Symptoms and signs of children with pneumonia on admission to hospital in the sampled hospitals
Time from onset of symptoms up to admission (days)
TCM hospitals (n = 598)
WM hospitals (n = 700)
7.4 ± 6.6
8.8 ± 7.5
1.2 ± 0.7
1.6 ± 1.7
5.8 ± 9.7
4.0 ± 6.7
93.6 ± 64.2
147.1 ± 120.7
2.6 ± 2.9
4.9 ± 5.0
2.2 ± 2.3
7.0 ± 15.0
Etiologic agents identified in children hospitalised with pneumonia in the sampled hospitals
1-3 years (N = 391)
4-7 years (N = 673)
8-14 years (N = 234)
M pneumoniae b
Treatment modalities in children hospitalised with pneumonia in the sampled hospitals
Number (n = 598)
Number (n = 700)
Third generation cephalosporin
Second generation cephalosporin
First generation cephalosporin
Chinese herbal extract injection
Chinese patent drugs
Clinical outcome at discharge
Symptom outcomes of children hospitalised with pneumonia in the sampled hospitals
2.0 ~ 6.3
2.0 ~ 6.8
2.6 ~ 3.2
2.0 ~ 3.1
0.4 ~ 0.8
0.2 ~ 0.6
0.5 ~ 2.8
0.5 ~ 6.0
3.0 ~ 5.7
4.8 ~ 10.9
7.3 ~ 12.9
7.3 ~ 13.1
Overall clinical outcome of children hospitalised with pneumonia in the sampled hospitals
Outcome at dischargea
Time from admission to recovery from symptoms (days)
TCM hospitals (n/N)
WM hospitals (n/N)
53.2 ± 51.5
63.5 ± 63.0
9.5 ± 4.9
8.2 ± 3.5
6.5 ± 9.1
3.1 ± 5.4
2.4 ± 2.0
3.4 ± 2.3
3.3 ± 2.2
3.8 ± 2.5
1.4 ± 1.6
1.7 ± 1.9
Duration of hospital stay
8.7 ± 5.8
9.0 ± 3.8
This cross-sectional study is the first of its kind investigating the clinical profile of children hospitalized with community-acquired pneumonia in China. Our sample was drawn from children of different ages admitted with pneumonia to 13 hospitals across eight eastern cities in China. The consecutive hospital charts covered four seasons. We believe the information gathered reflects current clinical characteristics of childhood CAP in China.
Children with histories of respiratory disease or allergy accounted for 41.0% of the 1298 cases. The percentage (12.4%) of childhood pneumonia cases with histories of recurrent pneumonia was high, similar to study findings elsewhere [18, 19]. Ozdemir and colleagues  in their sample of 595 hospitalized children found that 62 (10.4%) patients had histories of recurrent pneumonia. In our study, 10.2% of admitted children had recurrent upper respiratory tract infection (RURTI). Risk factors for RURTI are known to be atopy (allergy), daycare attendance, tobacco smoke or air pollution exposure, among others . Such correlations for our sample need further corroboration.
In our study, pneumonia patients with atopic condition were common. Percentages of children with histories of eczema, asthma, or allergic rhinitis were 10.0%, 4.1%, and 4.3%, respectively. Bronchial pneumonia was a complication of all asthma cases. There were also cases of undiagnosed asthma among patients with recurrent pneumonia. This seems to concur with other authors’ findings. For example, Ozdemir and colleagues  reported that 30.6% of pneumonia inpatients had histories of asthma. Youn and Lee  found that history of asthma might increase the risk of pneumonia caused by Mycoplasma pneumoniae. Our study found that onset of childhood pneumonia is closely associated with medical history, in particular with respiratory or atopic conditions. Therefore, attention should be focused on such children and preventive measures applied such as immunization [23, 24] and educating families about avoiding contact with allergens and other triggers.
Significant difference existed between TCM and WM hospitals in the presenting symptoms and signs at admission. The World Health Organization’s (WHO) guideline on the management of childhood pneumonia  has been widely adopted in developing countries. The guideline suggests that cough and dyspnea present high sensitivity and specificity as main indicators for pediatric pneumonia diagnosis. However, in China dyspnea is rarely applied to diagnose mild pediatric pneumonia because though respiratory rate is increased, it is still within normal range, especially in very young children. Instead, cough and auscultatory findings are more commonly used. In our study, the prevalence of cough at admission was similar between TCM hospitals and WM hospitals. These data are concordant with WHO data . Although there was significant difference between the two types of hospitals regarding other symptoms and signs, a large proportion of children presented with fever and rales.
Duration of symptoms and signs in children before admission in WM hospitals was markedly longer than in children in TCM hospitals. We suspect that the two types of hospitals differ in regard to criteria for admission (such as severity of disease), ability of the family to afford hospitalization, or bed availability. Further studies are required to explore relevant factors that influence hospital intake.
With the growing use of antibiotics in China, incidence of childhood bacterial pneumonia stabilized and declined between 1985 and 2008 . But pneumonia caused by other pathogens increased, especially respiratory syncytial virus and mixed bacterial and viral infections. As elsewhere in the world, China has seen a rise in pneumonia caused by M pneumoniae in school-age children [26, 27]. Our study showed that M pneumoniae accounted for 23.0% of all cases and was highest in preschool children, who comprised 30.8% of all M pneumoniae cases. Our previous randomised controlled trial  found that M pneumoniae pneumonia showed highest prevalence in preschool children, accounting for 43.6% of all cases. Studies in some countries, such as Korea, also found that M pneumoniae pneumonia was prevalent in 4 to 6 year-old children, reaching almost 60% [22, 27, 28]. Current evidence indicates that M pneumoniae pneumonia is appearing in increasingly younger children.
In our study, mixed pathogen infection was found in 14.4% of cases and was highest in preschool children at 22.0%. Some authors report that age is related closely to pathogen type in mixed infections, with M pneumoniae as one of the most common pathogens in such infections [29–31]. Our study found mixed infections with M pneumoniae accounting for the highest proportion of such infections of which the majority of cases were preschool children.
Pediatric pneumonia can be considered a syndrome , thus comprehensive treatment and management are needed [10, 23]. In China, treatment of childhood pneumonia involves myriad WM and TCM methods. In both types of hospitals, common modalities include intravenous injection of antibiotics and intravenous injection of Chinese herbal preparations. External therapy is also widely applied, mainly inhalation therapy in WM hospitals and external application of herbal medicine and cupping therapy in TCM hospitals.
Antibiotics were the mainstay of childhood pneumonia treatment in the 13 hospitals included in our study. Other authors [33–35] have reported that macrolides are more effective in shortening disease duration and reducing severity of M pneumoniae pneumonia compared with other antibiotics. Macrolides are also more effective for a wide range of bacterial pathogens [33, 35], which might be one of the reasons that in our study this class of antibiotics was widely used. However, macrolide resistance is a serious worldwide problem [36–38]. Suzuki and colleagues  reported that of 96 cases of M pneumoniae pneumonia in Yamagata, Japan, 83.0% were identified as macrolide-resistant. Cephalosporins are widely used for treating childhood pneumonia in China. In fact, there has been inappropriate use and abuse of cephalosporins in China [39, 40], where cephalosporins use was higher than Northern England (36% in 542 children ). In cases of pneumonia caused by M pneumoniae, cephalosporins are ineffective. In our study, among 1298 cases, 576 patients (44.4%) received third generation cephalosporins and 300 patients (23.1%) received second generation cephalosporins. In general, selection of antibiotics in China has not been based on drug sensitivity testing but on clinician experience or medical insurance policy. With the promulgation by the Chinese Ministry of Health in August 2012 of regulations on the rational use of antibiotics , it is hoped that arbitrary administration of antibiotics, especially for childhood pneumonia, will be curbed.
In the modernization drive, TCM injection in China was popularly used in both types of hospitals. There was a lot of literatures [43–50] reported that the effect of combined therapy with these injections plus conventional treatment for pediatric pneumonia was better than conventional treatment alone. Therefore, this could be explained as the reasons for their use. However, the adverse reaction must not to be overlooked as herb-drug interaction might exist. According to literature review, most common adverse reactions of Chinese herbal injections were rash and pruritus, diarrhea, or vomiting . The high incidence of adverse reaction may be related to physiological characteristics of children or irrational use and preparing technology. Thus, appropriate measures should be taken to reduce the occurrence of such events.
Length of hospitalization in our study was found to be shorter in TCM hospitals than that in WM hospitals. This may be related to the mildness of disease or turnover in ward beds as required by local health policy. Another possible reason for shorter hospital stay in TCM hospitals is that treatment that combines TCM and WM based on syndrome differentiation is more effective than WM alone in resolving symptoms, thus reducing disease duration. In our study, fewer patients in TCM hospitals than in WM hospitals were reported as having symptoms, such as cough and sputum, at discharge. Shorter hospital stay in TCM hospitals may also be attributed to lower emphasis on strict adherence to discharge guidelines. For example, patients deemed “cured” and who are therefore discharged in TCM hospitals would in WM hospitals be considered only “improved” and have a longer length of stay.
Treatment approach differs between TCM and WM. TCM treatment is based on syndrome differentiation in which individual signs and symptoms are evaluated and treated together holistically instead of the solitary symptom approach of WM. With pneumonia, TCM considers sputum an essential sign as part of the overall syndrome. Therefore, TCM clinicians focus on the presence of sputum by observation of signs or airway suctioning. Treatment is rendered based on the quantity, quality, and color of sputum. WM clinicians, on the other hand, view these finer points of sputum as less important, and assess and treat based simply on whether or not sputum is present. Indeed in our study, description of sputum was lacking in most of the cases in WM hospitals. TCM hospitals showed an advantage in relieving rales. This may be because more external therapy, such as herbal medicine application and cupping, was used in TCM hospitals.
The disappearance of rales may be associated with pathogen and previous medical history. Some pathogen induced pneumonia such as M pneumoniae pneumonia need more time to absorb inflammation, so rales usually lasted longer than the others. Children with recurrent respiratory disease were more susceptible to illness. Once they got pneumonia, they need more time to recovery than health children. Thus, we should pay more attention to such children and prevent them from pneumonia.
Another difference between TCM and WM hospitals in terms of treatment approach is aetiology diagnosis. As mentioned, TCM practitioners render treatment based on syndrome differentiation. As such, we suspect pathogen testing plays a less important role in guiding treatment than for WM practitioners. This may be the reason that in our study, pathogen testing was ordered less frequently in TCM hospitals than in WM hospitals. (National guidelines in China recommend pathogen testing for CAP [1, 10]).
Criteria for evaluating therapeutic effectiveness in childhood pneumonia between TCM and WM hospitals were about the same. But weighting of individual parameters was different. For example, based on guidelines [1, 10], fever normalization is foremost for assessing whether pneumonia is only improved or cured. Improvement of symptoms, such as cough, is used to evaluate the status of disease (cured, clinical improvement, or failed). Clinical cure of disease is based on the disappearance of rales (moist rales) through auscultation.
A limitation of our study is that this was a cross-sectional study. Our data was extracted from medical records at 13 hospitals. Although we exercised quality control to the best of our ability during the extraction process, still the quality and scope of the study were dependent on these records.
Another limitation is that patients in this study were drawn from eight cities in China. The data are not representative of childhood CAP elsewhere in China, especially non-urban areas where healthcare seeking behavior and delivery practices vary widely from those in metropolitan locales.
Our study presents the clinical characteristics of hospitalized children with pneumonia in eight eastern cities in China. Intravenous use of antibiotics was highly prevalent regardless of causative organism. As expected, intravenous use of herbal injections was more prevalent in TCM hospitals than in WM hospitals. This study finds that the basic characteristics of children with pneumonia admitted to the included TCM and WM hospitals are similar. Universal issues, such as inconsistent application of diagnostic criteria and treatment based on clinical experience instead of current guidelines, exist in both types of hospitals. Awareness of these and other shortcomings and taking necessary measures to overcome will help clinicians in China improve their care practice for children with pneumonia.
This study was supported by the project grant of the national TCM clinical research base key diseases-pediatric pneumonia (JDZX2012098). JP Liu and ZL Liu were partially supported by the grants of the 111 Project (No.B08006), the National Technological Platform of Clinical Evaluation and Research for New Herbal Medicinal Products (2011ZX09302-006-01-03(5)).
The authors gratefully acknowledge the assistance of Nissi S. Wang, MSc, in editing the manuscript and Liqiong Wang, MSc, in statistical analysis.
- Hu YM, Jiang ZF: Zhu Futang Textbook of Pediatrics. 2002, Beijing: People’s Medical Publishing House, 1199-1200. 7Google Scholar
- Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H: Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008, 86: 408-416. 10.2471/BLT.07.048769.View ArticlePubMedPubMed CentralGoogle Scholar
- Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H: Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004, 82: 895-903.PubMedGoogle Scholar
- Nair H, Simões EAF, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF, Feikin DR, Mackenzie GA, Moïsi JC, Roca A, Baggett HC, Zaman SMA, Singleton RJ, Lucero MG, Chandran A, Gentile A, Cohen C, Krishnan A, Bhutta ZQA, Arguedas A, Clara AW, Andrade AL, Ope M, Ruvinsky RO, Hortal M, McCracken JP, Madhi SA, Bruce N, Qazi SA, Morris SS: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013, 9875: 1380-1390.View ArticleGoogle Scholar
- UNICEF/WHO: Pneumonia: the forgotten killer of children. Wkly Epidemiol Rec. 2008, 83: 1-16.Google Scholar
- Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C: Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002, 2: 25-32. 10.1016/S1473-3099(01)00170-0.View ArticlePubMedGoogle Scholar
- Yan FY, Feng SH, Li S: Analysis of 2581 hospitalised pediatric patients. Modern Prev Med. 2008, 35: 388-389.Google Scholar
- Guan XH, Silk BJ, Li W, Fleischauer AT, Xing X, Jiang X, Yu H, Olsen SJ, Cohen AL: Pneumonia incidence and mortality in mainland China: systematic review of Chinese and English literature, 1985–2008. PLoS One. 2010, 5 (7): e11721-10.1371/journal.pone.0011721. doi:10.1371/journal.pone.0011721View ArticlePubMedPubMed CentralGoogle Scholar
- Wang L, Wang Y, Jin S, Wu Z, Chin DP, Koplan JP, Wilson ME: Emergence and control of infectious diseases in China. Lancet. 2008, 372: 1598-1605. 10.1016/S0140-6736(08)61365-3.View ArticlePubMedGoogle Scholar
- Chinese Society of Pediatrics, Pediatric Respiratory Group: Guidelines for the management of community-acquired childhood pneumonia. Chin J Pediatr. 2007, 45: 83-90.Google Scholar
- Wang XF, Dong D, Liu F, Yu JE, Lü YX, Jiang ZY, Xu YJ, Xiao XT, Liu XD, Ma GX: Pneumonia in children:analysis of common etiology in 840 cases. Chin J Pract Pediatr. 2005, 20: 239-241.Google Scholar
- Wang LN, Wang XF, Yuan XF, Li YN, Gao SB, Jiang ZY, Hong LJ, Zhang W, Hu XY, Liu XF, Wang MQ, Li WW, Xu YJ, Li LX, Yang Y: Research of TCM clinical validation scheme on children’s pneumonia with “wind and heat blocking the lung syndrome” and “phlegm-heat obstructing the lung syndrome” by multi-center randomized controlled study. Chin Pediatr Integr Tradit West Med. 2010, 2: 386-391.Google Scholar
- Cui ZZ, Chen HX, Huang Y: A study of myoplasma infection in 366 cases of children’s community acquired pneumonia. Chin Med. 2010, 5: 71-72.Google Scholar
- Yao KH, Wang LB, Zhao GM, Zheng TJ, Deng L, Zhao RZ, Deng QL, Hu YH, Yu SJ, Shen XZ, Yang YH: Surveillance of serotype distribution of Streptococcus pneumonia isolated from children with pneumonia in children’s hospitals located in Beijing, Shanghai, Guangzhou and Shenzhen. Chin J Evid Based Pediatr. 2008, 3: 426-432.Google Scholar
- State Administration of Traditional Chinese Medicine of the People’s Republic of China: Criteria of diagnosis and therapeutic effect of diseases and syndromes in traditional Chinese medicine (ZY/T001.1 ~ 001.9-94). 1994, Nanjing: Nanjing University Press, 78-Google Scholar
- Ministry of Health of the People’s Republic of China: Criteria of diagnosis and therapeutic effect of pediatric disease. 1997, Shanghai: Shanghai Medical University Press, 12-127.Google Scholar
- Chinese Medical Association, Chinese Society of Pediatrics, Pediatric Respiratory Group: Clinical understanding and principles of management of recurrent respiratory tract infections. Chin J Pediatr. 2008, 46: 108-110.Google Scholar
- Li HM, Jiang ZF, Jiang QB, Zhao SY: Underlying illnesses and diagnosis of recurrent pneumonia in children. Chin J Pract Pediatr. 2004, 19: 153-155.Google Scholar
- Owayed AF, Campbell DM, Wang EEL: Underlying causes of recurrent pneumonia in children. Arch Pediatr Adolesc Med. 2000, 154: 190-194. 10.1001/archpedi.154.2.190.View ArticlePubMedGoogle Scholar
- Ozdemir O, Sari S, Bakirtas A, Zorlu P, Ertan U: Underlying diseases of recurrent pneumonia in Turkish children. Turk J Med Sci. 2010, 40: 25-30.Google Scholar
- Ballow M, Adkinson NFJ, Adkinson NFJ, Bochner BS: Approach to the patient with recurrent infections. Middleton’s Allergy: Principles and Practice. Edited by: Busse WW, Holgate ST, Lemanske RFJr, Simons FER. 2008, Philadelphia, PA: Elsevier Mosby, 1405-1421. 7Google Scholar
- Youn YS, Lee KY: Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012, 55: 42-47. 10.3345/kjp.2012.55.2.42.View ArticlePubMedPubMed CentralGoogle Scholar
- Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR, St Peter SD, Stockwell JA, Swanson JT: The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011, 53: e25-e76. 10.1093/cid/cir531.View ArticlePubMedGoogle Scholar
- British Thoracic Society of Standards of Care Committee: BTS guidelines for the management of community acquired pneumonia in childhood. Thorax. 2002, 57 (Suppl 1): i1-i24. doi:10.1136/thx.57.suppl_1.i1View ArticleGoogle Scholar
- World Health Organization: Technical bases for the WHO recommendations on the management of pneumonia in children at first level health facilities. 1991, Geneva, Switzerland: World Health OrganizationGoogle Scholar
- Chalker VJ, Stocki T, Litt D, Bermingham A, Watson J, Fleming DM, Harrison TG: Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012, 17: i1-i5. pii = 20081. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20081.Google Scholar
- Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, Kim JC: Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010, 10: 48-10.1186/1471-2431-10-48. doi:10.1186/1471-2431-10-48View ArticlePubMedPubMed CentralGoogle Scholar
- Eun BW, Kim NH, Choi EH, Lee HJ: Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect. 2008, 56: 326-331. 10.1016/j.jinf.2008.02.018.View ArticlePubMedGoogle Scholar
- Chen LL, Cheng YG, Chen ZM, Li SX, Li XJ, Wang YS: Mixed infections in children with Mycoplasma pneumoniae pneumonia. Chin J Pediatr. 2012, 50: 211-215.Google Scholar
- Numazaki K, Chiba S, Umetsu M, Tanaka T, Yoshimura H, Kuniya Y, Miura J, Adachi N, Ukae S, Mori T, Ueda D, Hotsubo T, Sato T: Etiological agents of lower respiratory tract infections in Japanese children. In Vivo. 2004, 18: 67-72.PubMedGoogle Scholar
- Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, Kallergi K, Kafetzis DA, Constantopoulos A, Papadopoulos NG: Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004, 39: 681-686. 10.1086/422996.View ArticlePubMedGoogle Scholar
- Langley JM, Bradley JS: Defining pneumonia in critically ill infants and children. Pediatr Crit Care Med. 2005, 6 (Supp 3): 9-13.View ArticleGoogle Scholar
- Galova K, Sufliarska S, Kukova Z, Danisovicova A, Hrachova I, Grausova S, Marinova I, Krizan S, Stopkova K, Stahorska A, Durcanska K, Raskova J, Krupova I, Krcméry V: Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. Chemotherapy. 1996, 42: 231-234. 10.1159/000239448.View ArticlePubMedGoogle Scholar
- Kabra SK, Lodha R, Pandey RM: Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev. 2006, 3: CD004874Google Scholar
- Wang DM, Wang XH, Lu Q, Hong JG, Zhou YF: Clinical effectiveness and safety of azithromycin in the treatment of childhood pneumonia. Chin J Pract Pediatr. 2003, 18: 749-750.Google Scholar
- Bebear C: Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what?. Clin Infect Dis. 2012, 39: 1650-1651.View ArticleGoogle Scholar
- Xin DL, Han X, Mi ZH: Macrolide resistance and molecular mechanisms in Mycoplasma pneumoniae. Chin J Lab Med. 2008, 31: 543-546.Google Scholar
- Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y: Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009. Pediatr Infect Dis J. 2013, 32: 237-240.PubMedGoogle Scholar
- Ding H, Yang Y, Chen Y, Wang Y, Fan S, Shen X: Antimicrobial usage in paediatric intensive care units in China. Acta Paediatr. 2008, 97: 100-104.View ArticlePubMedGoogle Scholar
- Huang FH, Lin Y, Zhou Y, Zhang CH, Xu X: Antibacterial use by line category in pediatric outpatient and emergency departments of a hospital: a survey. Chin J Nosocomiol. 2010, 20: 87-88.Google Scholar
- Elemraid MA, Rushton SP, Thomas MF, Spencer DA, Eastham KM, Gennery AR, Clark J, E. and North East of England Paediatric Respiratory Infection Study Group: Changing clinical practice: management of paediatric community-acquired pneumonia. J Eval Clin Pract. 2013, Available online: doi:10.1111/jep.12091.Google Scholar
- Xiao YH, Li LJ: Legislation of clinical antibiotic use in China. Lancet Infec Dis. 2013, 13: 189-191. 10.1016/S1473-3099(13)70011-2.View ArticleGoogle Scholar
- Wang XQ, Li H, Xiong NY, Zhu QH, Wang X, Zhang SL: Clinical and laboratory study on outcomes of Staphylococcus aureus pneumonia by three scenarios of treatment. Chin Rem Clin. 2010, 10: 741-743.Google Scholar
- Zhan HZ, Yan HX: Clinical observation of Tanreqing injection combined with azithromycin as sequential therapy for children with mycoplasma pneumonia. J Clin Pulm Med. 2013, 18: 1435-1436.Google Scholar
- Zhu ZW: The study of danshen injection in adjuvant treatment of infant bronchial pneumonia. Asia Pac Tradit Med. 2013, 9: 151-153.Google Scholar
- Zhang YL: Clinical observation of danshen injection combined with azithromycin in the treatment of children with mycoplasma pneumoniae pneumonia. Chin J Clin Ration Drug Use. 2013, 6: 24-25.Google Scholar
- Li XL, Huang BF: Efficacy observation on treating 68 cases of hold breath pneumonia by Xiyanping oxygen pump spray therapy. Clin J Chin Med. 2013, 5: 26-27.Google Scholar
- Wen JF, Wang ZX, Qu YH: Meta-analysis of xiyanping injection treatment for bronchial pneumonia. Pract Pharm Clin Rem. 2012, 15: 199-201.Google Scholar
- Jiao J: Observation on therapeutic effects of asarone with mechanical vibration sputum elimilations for brochopneumonia in children. J Paediatr Pharm. 2012, 18: 24-26.Google Scholar
- Yang QC, Wu DR, Mao W, Liu XS, Bao K, Lin QZ, Lu FH, Zou C, Li C: Chinese medical herbs for childhood pneumonia: a systematic review of effectiveness and safety. Evid Based Complement Alternat Med. 2013, Available online: doi:10.1155/2013/203845Google Scholar
- Zhang LX, Li M, Rong P, Ma R: Analysis and countermeasures of adverse drug reactions of traditional Chinese medicine injections in children. Chin J Chin Mater Med. 2012, 37: 2807-2809.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/367/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.